Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease
- 15 March 2010
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 105 (6), 869-873
- https://doi.org/10.1016/j.amjcard.2009.11.041
Abstract
No abstract availableKeywords
Funding Information
- European Society of Cardiology
- Hellenic Atherosclerosis Society
- British Heart Foundation
- Hellenic Cardiological Society
- Hellenic Heart Foundation
This publication has 30 references indexed in Scilit:
- Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart DiseaseCirculation, 2008
- Amino-Terminal Pro–B-Type Natriuretic Peptide Testing in Neonatal and Pediatric PatientsThe American Journal of Cardiology, 2008
- The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulationInternational Journal of Cardiology, 2007
- B-type natriuretic peptide in paediatric patients with congenital heart diseaseEuropean Heart Journal, 2006
- Exercise Intolerance in Adult Congenital Heart DiseaseCirculation, 2005
- B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failureThe American Journal of Cardiology, 2005
- Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart diseaseThe American Journal of Cardiology, 2005
- Increased Atrial and Brain Natriuretic Peptides in Adults With Cyanotic Congenital Heart DiseaseCirculation, 2004
- Congenital heart disease: the original heart failure syndromeEuropean Heart Journal, 2003
- Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart DiseaseCirculation, 2002